award

Dual inhibition of PARP and STAT3 as a novel therapeutic approach for triple-negative breast cancer

  • Award Number: R21CA270591

  • ORGANIZATION: NATIONAL CANCER INSTITUTE

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 02/01/2024

  • PERIOD OF PERFORMANCE END DATE: 01/31/2026